Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2005
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/20/2005CA2135251C Crystal modification of (4-cyclopropyl-6-methyl-pyrimidin-2-yl)-phenyl-amine
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118581A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
12/15/2005WO2005118559A1 A type of formyl peptide receptor-like 1 regulator, preparation method and use thereof
12/15/2005WO2005118558A2 Pyrimidine compounds and use thereof
12/15/2005WO2005118557A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118542A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/15/2005WO2005118540A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
12/15/2005WO2005117883A1 Modulators of muscarinic receptors
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005117867A2 Monocyclic heterocycles as kinase inhibitors
12/15/2005US20050277658 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
12/15/2005US20050277655 Pyrazolopyrimidines
12/15/2005US20050277654 4,5-Disubstituted-2-aryl pyrimidines
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277644 Pyridine analogs as C5a antagonists
12/15/2005US20050277640 Pyrimidine derivatives for treatment of hyperproliferative disorders
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/15/2005CA2568165A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005CA2568163A1 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
12/15/2005CA2568159A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/15/2005CA2563831A1 Monocyclic heterocycles as kinase inhibitors
12/14/2005EP1604991A1 Antitumor effect potentiator and antitumor agent
12/14/2005EP1603906A2 Process for synthesising useful intermediates for the preparation of alpha v beta 3 receptor antagonists
12/14/2005EP1603888A1 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazoline-4-yl) acetic acids as anti-viral agents, especially against cytomegalo viruses
12/14/2005EP1603887A1 Hiv replication inhibiting pyrimidines and triazines
12/14/2005EP1603886A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors
12/14/2005EP1603876A1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005CN1708539A Novel polymers for use in optical devices
12/14/2005CN1708499A Purine compounds and use thereof as cannabinoid receptor ligands
12/14/2005CN1708485A Electroluminescent device
12/14/2005CN1708306A Quinazolinone compounds as calcilytics
12/14/2005CN1706833A Formyl peptide-like acceptor-1 regulator and its prepn and use
12/14/2005CN1231472C Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/14/2005CA2471177A1 Novel combi-molecules having egfr and dna targeting properties
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974868 A 6-(7-((2-(phenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2, 3-triazolo(4,5-d)pyrimidin-3-yl)-tetrahydro-2,2-dimethyl-4H-cyclopentane-1,2-diol derivative; anticoagulants; myocardial infarction, strokes; thrombolytic and antiischemic agents;
12/13/2005US6974830 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974485 Oxidative hair dyes containing plant extracts
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115992A1 Theramutein modulators
12/08/2005WO2005115984A2 Large conductance calcium-activitated k channel opener
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005097757A3 Nucleoside derivatives and therapeutic use thereof
12/08/2005WO2005060654A3 Mitotic kinesin inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272823 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272638 Improved bioavailability; for oral and intracolonic administration
12/08/2005US20050272036 Ketones
12/08/2005US20050271715 Conjugate having a cleavable linkage for use in a liposome
12/08/2005DE19640756B4 Verfahren zur Herstellung von 4,6-Dihydroxypyrimidin Process for the preparation of 4,6-dihydroxypyrimidine
12/08/2005DE102004017662B3 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2567813A1 Theramutein modulators
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/07/2005EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
12/07/2005EP1601658A1 Crystalline ammonium salts of rosuvastatin
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1064263B1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113556A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
12/01/2005WO2005113554A2 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
12/01/2005WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005WO2005113516A1 Uracil-type gonadotropin-releasing hormone receptor antagonists and methods related thereto
12/01/2005WO2005113515A1 Pyrimidines for use as plk inhibitors
12/01/2005WO2005113514A2 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113506A1 Compounds and compositions as ppar modulators
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005112938A2 Disalt inhibitors of il-12 production
12/01/2005WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 427